Artwork

Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

CAR-T and CAR-NK cell therapies

27:35
 
Share
 

Manage episode 372381195 series 2902208
Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of Talking Techniques, Ritwika Biswas, Field Scientist at Sino Biological US Inc. (PA, USA), walks us through the chimeric antigen receptor (CAR) development process and how T and natural killer (NK) cells can be utilized to carry these modular synthetic molecules. Ritwika also addresses the safety and efficacy of these cell therapies as well as the ethical considerations around them.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

60 episodes

Artwork

CAR-T and CAR-NK cell therapies

Talking Techniques

11 subscribers

published

iconShare
 
Manage episode 372381195 series 2902208
Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of Talking Techniques, Ritwika Biswas, Field Scientist at Sino Biological US Inc. (PA, USA), walks us through the chimeric antigen receptor (CAR) development process and how T and natural killer (NK) cells can be utilized to carry these modular synthetic molecules. Ritwika also addresses the safety and efficacy of these cell therapies as well as the ethical considerations around them.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

60 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play